Jeff Sharman, MD, director of hematology research at the US Oncology Network and director of research at Willamette Valley Cancer Institute, joins The Oncology Brothers to discuss how to manage chronic lymphocytic leukemia (CLL) using a treatment algorithm. They cover the important nuances of CLL management, choosing the right Bruton’s tyrosine kinase inhibitor, and much more.